tetradecanoylphorbol acetate has been researched along with procaterol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujiu, T; Kato, M; Kimura, H; Mirza, ZN; Mochizuki, H; Morikawa, A; Suzuki, M; Tachibana, A; Tokuyama, K | 1 |
Fujiu, T; Kato, M; Kimura, H; Morikawa, A; Suzuki, M; Tachibana, A | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and procaterol
Article | Year |
---|---|
Fenoterol inhibits superoxide anion generation by human polymorphonuclear leukocytes via beta-adrenoceptor-dependent and -independent mechanisms.
Topics: Adrenergic beta-Agonists; Albuterol; Dose-Response Relationship, Drug; Fenoterol; Free Radical Scavengers; Humans; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Procaterol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Superoxides; Tetradecanoylphorbol Acetate | 2002 |
Inhibition by fenoterol of human eosinophil functions including beta2-adrenoceptor-independent actions.
Topics: Adrenergic beta-Agonists; Albuterol; Anti-Inflammatory Agents; CD11b Antigen; Cell Adhesion; Cell Degranulation; Cells, Cultured; Depression, Chemical; Eosinophils; Fenoterol; Flow Cytometry; Humans; Procaterol; Superoxides; Tetradecanoylphorbol Acetate | 2002 |